Gene · 23521
Papers2,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen. | Oncogene | 2020 | 32843722 | PubTator, text mining | PubMed |
| Human epidermal stem cell differentiation is modulated by specific lipid subspecies. | Proc Natl Acad Sci U S A | 2020 | 32843345 | PubTator, text mining | PubMed |
| Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer. | Clin Cancer Res | 2020 | 32826327 | PubTator, text mining | PubMed |
| TATA box binding protein and ribosomal protein 4 are suitable reference genes for normalization during quantitative polymerase chain reaction study in bovine mesenchymal stem cells. | Asian-Australas J Anim Sci | 2020 | 32819081 | PubTator, text mining | PubMed |
| C9orf72 in myeloid cells suppresses STING-induced inflammation. | Nature | 2020 | 32814898 | PubTator, text mining | PubMed |
| Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection. | J Exp Med | 2020 | 32812031 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target. | Sci Rep | 2020 | 32807831 | PubTator, text mining | PubMed |
| L-Cystine-Containing Hair-Growth Formulation Supports Protection, Viability, and Proliferation of Keratinocytes. | Clin Cosmet Investig Dermatol | 2020 | 32801826 | PubTator, text mining | PubMed |
| Identification and Validation of Reference Genes Selection in Ovarian Cancer Exposed to Hypoxia. | Onco Targets Ther | 2020 | 32801765 | PubTator, text mining | PubMed |
| An assessment of serum-dependent impacts on intracellular accumulation and genomic response of per- and polyfluoroalkyl substances in a placental trophoblast model. | Environ Toxicol | 2020 | 32790152 | PubTator, text mining | PubMed |
| Sex-Specific Transcriptome Differences in Human Adipose Mesenchymal Stem Cells. | Genes (Basel) | 2020 | 32784482 | PubTator, text mining | PubMed |
| Molecular Transducers of Human Skeletal Muscle Remodeling under Different Loading States. | Cell Rep | 2020 | 32755574 | PubTator, text mining | PubMed |
| Optimisation of Tet-On inducible systems for Sleeping Beauty-based chimeric antigen receptor (CAR) applications. | Sci Rep | 2020 | 32753634 | PubTator, text mining | PubMed |
| VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines. | Int J Mol Sci | 2020 | 32751795 | PubTator, text mining | PubMed |
| Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle. | Aging Cell | 2020 | 32744385 | PubTator, text mining | PubMed |
| ASIC1a Inhibitor mambalgin-2 Suppresses the Growth of Leukemia Cells by Cell Cycle Arrest. | Acta Naturae | 2020 | 32742733 | PubTator, text mining | PubMed |
| PYGM mRNA expression in McArdle disease: Demographic, clinical, morphological and genetic features. | PLoS One | 2020 | 32735634 | PubTator, text mining | PubMed |
| Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer. | Mol Oncol | 2020 | 32734688 | PubTator, text mining | PubMed |
| Identification and targeting of selective vulnerability rendered by tamoxifen resistance. | Breast Cancer Res | 2020 | 32727562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/papers?page=53